Orthofix Reports First Quarter 2026 Results
Orthofix Medical Inc. reported its financial results for the first quarter of 2026, highlighting steady execution following actions in the spine commercial channel. The company reaffirmed its full-year financial guidance based on this performance.
LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2026, reflecting steady execution following recent spine commercial channel actions. Based on first-quarter performance, the Company reaffirmed its full-year 2026 financial guidance. All pro forma measures contained within this release exclude the impact of the Company’s decision to discontinue its M6™ pr